Tasly Pharmaceutical : listed in Top 100 of Chinese Pharmaceutical Industry in 2015 (2016-08-10)
August 11, 2016 at 12:22 pm EDT
Share
The 33rd National Pharmaceutical Industrial Inforamation Annual Conference, sponsored by China's pharmaceutical industry information center, wrapped up from July 23rd to 26th in Chongqing, China. Top 100 Enterprises List of Chinese Pharmaceutical Industrial Enterprises of 2015 was published on the conference. And Tasly Holding Group won Top 26. General Manager of Tasly Pharmaceutical Group, Mr. Yonghong Zhu, attended the conference and made a speech with theme of 'Opportunities and Challenges faced by Chinese National Pharmaceutical Enterprises in the New Era'.
From the point of view of industrial chain, GM Yonghong Zhu gave an introduction about Tasly's new measures including overall internationalization, innovative research, smart manufacture, integrated marketing and crossover cooperation in the new economic norm in China. And he told that Tasly would extend its business towards innovation and service oriented type with the entity as the center and would realize the integration of great-health industry system by means of technology, capital and brand. His report won great recognition from the experts who praised highly on internalization exploitation and rapid development of Tasly.
During the conference, Tasly Holding Group, along with other Top 100 pharmaceutical industrial companies such as Guangzhou Pharmaceutical Holdings Limited,Xian-Janssen Pharmaceutical Ltd, Huabei Pharmaceutical Group Ltd, and Ali Health Information Technology Co.,Ltd initiated to launch the Chinese Pharmaceutical Enterprises Social Responsiblity Alliance. The Alliance aims to promote social responsiblity of pharmaceutical enterprises and regards the combination of enterprises social ability with the competiveness as the mission. Thus, the Allicance has made promises in terms of medicine supply guarantee, medicine quality and innovation, medicine tracing system building, doctors traning and patient health education as well as social relief aid, etc.
(Translated by Anna Si)
Tianjin Tasly Pharmaceutical Co. Ltd. published this content on 10 August 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 August 2016 16:22:04 UTC.
Original documenthttp://www.tasly.com/show.aspx?id=11539&cid=22
Public permalinkhttp://www.publicnow.com/view/41EEC00FD089214C92CB90950ED07278D04F6438
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.